# EDGAR Filing Document

**Accession Number:** 0000310354
**File Stem:** 0001437749-26-003002
**Filing Date:** 2026-2
**Character Count:** 39394
**Document Hash:** 4c908ed49eded2881fbda815a2cd02b4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-26-003002.hdr.sgml**: 20260204

**ACCESSION NUMBER**: 0001437749-26-003002

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20260129

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260204

**DATE AS OF CHANGE**: 20260204

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** STANDEX INTERNATIONAL CORP/DE/
- **CENTRAL INDEX KEY:** 0000310354
- **STANDARD INDUSTRIAL CLASSIFICATION:** REFRIGERATION & SERVICE INDUSTRY MACHINERY [3580]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 310596149
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-07233
- **FILM NUMBER:** 26599006

**BUSINESS ADDRESS:**
- **STREET 1:** 23 KEEWAYDIN DRIVE
- **STREET 2:** SUITE 300
- **CITY:** SALEM
- **STATE:** NH
- **ZIP:** 03079
- **BUSINESS PHONE:** 603-893-9701

**MAIL ADDRESS:**
- **STREET 1:** 23 KEEWAYDIN DRIVE
- **STREET 2:** SUITE 300
- **CITY:** SALEM
- **STATE:** NH
- **ZIP:** 03079

?xml version='1.0' encoding='ASCII'? sxi20260129_8k.htm

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**FORM 8-K** 

**Current Report** 

**Pursuant to Section 13 or 15(d) of** 

**the Securities Exchange Act of 1934** 

**Date of Report (Date of earliest event reported): January 29, 2026**

## STANDEX INTERNATIONAL CORPORATION
**(Exact name of registrant as specified in its charter)** 

------

---

| | | |
|:---|:---|:---|
| **Delaware** | **1-7233** | **31-0596149** |
| **(State or other jurisdiction of**<br> **incorporation or organization)** | **(Commission**<br> **File Number)** | **(IRS Employer**<br> **Identification No.)** |

---

---

| | |
|:---|:---|
| **23 Keewaydin Drive, Salem, New Hampshire** | **03079** |
| **(Address of principal executive offices)** | **(Zip Code)** |

---

**Registrant**'**s telephone number, including area code: (603) 893-9701**

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| &nbsp;&nbsp;&nbsp; Common Stock, Par Value $1.50 Per Share | SXI | New York Stock Exchange |

---

**Not applicable** 

**(Former name or former address, if changed since last report)** 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (*see* General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Emerging growth company ☐

If an emerging growth company, indicates by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Standex International Corporation** 

**SECTION 2** – **FINANCIAL INFORMATION**

 **ITEM 2.02** – **RESULTS OF OPERATIONS AND FINANCIAL CONDITIONS**

On January 29, 2026, the registrant issued a press release announcing earnings for the second quarter ended December 31, 2025. A copy of the release is furnished herewith as Exhibit 99 and is incorporated herein by reference. This Current Report on Form 8-K and the press release attached hereto are being furnished by Standex International Corporation pursuant to item 2.02 of Form 8-K.

**SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS**

**ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS**

(c) Exhibits – The following exhibit is provided as part of the information furnished under Item 2.02 of this Current Report on Form 8-K.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exhibit No. | Description |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;99 | [Press Release of Standex International Corporation dated January 29, 2026 regarding Second Quarter Financial Results](ex_913968.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**FORWORD-LOOKING STATEMENTS** 

This current report on Form 8-K contains "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995 (the "Act") that are intended to come within the safe harbor protection provided by the Act. By their nature, all forward-looking statements involve risks and uncertainties, and actual results may differ materially from those contemplated by the forward-looking statements. Several factors that could materially effect the Corporation's actual results are identified in the press release as well as in the Corporation's Annual Report on Form 10-K, as amended, for the fiscal year ended June 30, 2025.

------

**<u>SIGNATURE</u>** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

**<u>STANDEX INTERNATIONAL CORPORATION</u>** 

(Registrant)

---

| | |
|:---|:---|
| /s/ Ademir Sarcevic | /s/ Ademir Sarcevic |
|  | **Ademir Sarcevic**<br> **Chief Financial Officer**  |
|  | Date: February 4, 2026 |
|  | Signing on behalf of the registrant and as principal financial officer |

---

## Ex-99

**Exhibit 99**

---

| | |
|:---|:---|
| ![logo.jpg](logo.jpg) | NEWS RELEASE |

---

STANDEX INTERNATIONAL CORPORATION ■ SALEM, NH 03079 ■ TEL (603) 893-9701 ■ WEB www.standex.com

**STANDEX REPORTS FISCAL SECOND QUARTER 2026 FINANCIAL RESULTS** 

● **In Q2 FY26, Sales Increased 16.6% YOY to $221.3 Million; New Products Sales Grew ~13% and Sales into Fast Growth Markets Contributed ~28% of Total Sales** 

● **In Q2 FY26, Sales Increased 6.4% YOY Organically; Electronics Increased 11.1% YOY Organically** 

● **Record Quarterly Order Intake with Book to Bill of 1.04; Electronics Book to Bill of 1.08** 

● **Q2 FY26 GAAP Operating Margin of 16.1%; Adjusted Operating Margin of 19.0%, Up 30 bps YOY** 

● **Reiterating FY26 Sales Outlook of >$110 Million Over FY25; Fast Growth Market Sales to Grow >45% and Exceed $270 Million; Plan to Release >15 New Products, Contributing ~300 bps of Growth** 

**SALEM, NH** – **January 29, 2026** – <u>Standex International Corporation</u> **(NYSE: SXI)** today reported financial results for the second quarter of fiscal year 2026 ended December 31, 2025.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| Summary Financial Results - Total |  |  |  |  |  |
| ($M except EPS and Dividends) | **2Q26** | **2Q25** | **1Q26** | **Y/Y** | **Q/Q** |
| Net Sales | $221.3 | $189.8 | $217.4 | 16.6% | 1.8% |
| Operating Income – GAAP | $35.6 | $8.5 | $29.6 | 320.3% | 20.0% |
| Operating Income – Adjusted | $42.2 | $35.5 | $41.6 | 18.9% | 1.4% |
| Operating Margin % - GAAP | 16.1% | 4.5% | 13.6% | + 1160 bps | + 250 bps |
| Operating Margin % - Adjusted | 19.0% | 18.7% | 19.1% | + 30 bps | - 10 bps |
| Net Income from Continuing Ops – GAAP | $20.6 | $1.3 | $15.8 | 1501.9% | 30.4% |
| Net Income from Continuing Ops – Adjusted | $25.1 | $22.9 | $24.0 | 9.5% | 4.3% |
| EBITDA | $45.1 | $16.1 | $39.7 | 180.3% | 13.5% |
| EBITDA margin | 20.4% | 8.5% | 18.3% | + 1190 bps | + 210 bps |
| Adjusted EBITDA | $47.2 | $39.6 | $47.1 | 19.2% | 0.2% |
| Adjusted EBITDA margin | 21.3% | 20.9% | 21.7% | + 40 bps | - 40 bps |
| Diluted EPS – GAAP | $0.17 | $0.07 | $1.25 | 145.6% | -86.4% |
| Diluted EPS – Adjusted | $2.08 | $1.91 | $1.99 | 8.9% | 4.5% |
| Dividends per Share | $0.34 | $0.32 | $0.32 | 6.3% | 6.3% |
| Free Cash Flow | $13.0 | $2.2 | $10.4 | 506.5% | 25.5% |
| Net Debt to EBITDA | 2.3x | 2.9x | 2.4x | -20.8% | -5.8% |

---

*\*Adjusted operating income, adjusted operating margin, and adjusted EPS for all periods now also exclude amortization expense from acquired intangible assets.*

Commenting on the quarter's results, President and Chief Executive Officer David Dunbar said, "We delivered strong top-line results and operating performance in the fiscal second quarter. Our sales increased 16.6% year-on-year to $221.3 million driven by 7% contribution from new products and 28% contribution from sales into fast growth markets. We recorded 6.4% organic growth and book to bill of 1.04, led by our Electronics segment which grew 11.1% organically with book to bill of 1.08. We are well positioned to deliver mid-to-high single digit organic growth in the fiscal third quarter, primarily driven by new product launches, strong tailwinds in the electrical grid, defense and aviation end markets, and improving general industrial markets. Sales from fast growth markets totaled approximately $61 million in the fiscal second quarter and are expected to exceed $270 million in fiscal year 2026.

------

Adjusted operating margin expanded 30 basis points year-on-year to 19.0%. We paid down approximately $10 million of debt in the fiscal second quarter, and our net leverage ratio was reduced to 2.3x."

**Fiscal Third Quarter 2026 Outlook**

In fiscal third quarter 2026, on a year-on-year basis, the Company expects significantly higher revenue, driven by mid-to- high single digit organic growth from higher sales into fast growth end markets and increased new product sales, and slightly higher adjusted operating margin due to higher volume and favorable product mix, partially offset by growth investments and higher medical costs.

On a sequential basis, the Company expects slightly to moderately higher revenue, driven by increased contributions from fast growth end markets and new product sales, and slightly to moderately higher adjusted operating margin due to higher volume and pricing and productivity initiatives, partially offset by growth investments.

**Fiscal Year 2026 Outlook**

The Company is reiterating its fiscal year 2026 sales outlook. In fiscal year 2026, barring any unforeseen economic, global trade, or tariffs related disruptions, the Company expects revenue to grow by over $110 million, driven by mid-to-high single digit organic growth in Electronics, double-digit organic growth in Engineering Technologies, and the contribution from recent acquisitions. The Company remains on course to release over fifteen new products that it expects will contribute approximately 300 bps of incremental growth. Sales from fast growth markets are on track to grow over 45% year-on-year and exceed $270 million. The Company expects continued adjusted operating margin expansion in fiscal year 2026.

**Second Quarter Segment Operating Performance**

**<u>Electronics (52% of sales; 63% of segment adjusted operating income)</u>**

---

| | | | |
|:---|:---|:---|:---|
|  | **2Q26** | **2Q25** | **% Change** |
| Electronics ($M) |  |  |  |
| Revenue | 115.7 | 95.9 | 20.6% |
| GAAP Operating Income | 29.8 | 17.4 | 70.9% |
| GAAP Operating Margin % | 25.7 | 18.2 |  |
| Adjusted Operating Income\* | 33.3 | 26.5 | 25.7% |
| Adjusted Operating Margin %\* | 28.8 | 27.6 |  |

---

\* Excludes the amortization of acquired intangible assets; Q2 FY25 restated to exclude the amortization of acquired intangible assets

Revenue increased approximately $19.7 million or 20.6% year-on-year, reflecting organic growth of 11.1%, an acquisition benefit of 9.1%, and a foreign currency benefit of 0.4%. Organic growth was driven by sales into fast growth markets and increased new product sales. Adjusted operating income increased approximately $6.8 million or 25.7% year-on-year due to higher volume, pricing initiatives, and product mix.

The segment had a book-to-bill ratio of approximately 1.08 in the fiscal second quarter, with orders of approximately $125 million.

In fiscal third quarter 2026, on a sequential basis, the Company expects slightly to moderately higher revenue, reflecting higher sales into fast growth end markets and increased new product sales. The Company expects similar adjusted operating margin, primarily due to product mix and continued strategic growth investments.

------

**<u>Engineering Technologies (14% of sales; 11% of segment adjusted operating income)</u>**

---

| | | | |
|:---|:---|:---|:---|
|  | **2Q26** | **2Q25** | **% Change** |
| Engineering Technologies ($M) |  |  |  |
| Revenue | 30.6 | 22.7 | 35.3% |
| GAAP Operating Income | 4.4 | 3.7 | 18.6% |
| GAAP Operating Margin % | 14.3 | 16.3 |  |
| Adjusted Operating Income\* | 5.8 | 3.7 | 56.6% |
| Adjusted Operating Margin %\* | 18.9 | 16.3 |  |

---

\* Excludes the amortization of acquired backlog and acquired intangible assets

Revenue increased approximately $8.0 million or 35.3% year-on-year reflecting a 33.4% benefit from the McStarlite acquisition, organic growth of 1.2%, and a foreign currency benefit of 0.6%. Organic growth was suppressed by delays in customer project timing. Adjusted operating income increased approximately $2.1 million or 56.6% year-on-year reflecting higher volume.

In fiscal third quarter 2026, on a sequential basis, the Company expects moderately to significantly higher revenue, due to growth in new product sales and more favorable project timing, and slightly to moderately higher adjusted operating margin due to higher volume.

**<u>Scientific (9% of sales; 9% of segment adjusted operating income)</u>**

---

| | | | |
|:---|:---|:---|:---|
|  | **2Q26** | **2Q25** | **% Change** |
| Scientific ($M) |  |  |  |
| Revenue | 19.5 | 18.5 | 5.5% |
| GAAP Operating Income | 4.5 | 4.7 | -4.9% |
| GAAP Operating Margin % | 23.0 | 25.5 |  |
| Adjusted Operating Income\* | 4.7 | 5.0 | -4.9% |
| Adjusted Operating Margin %\* | 24.2 | 26.9 |  |

---

\* Excludes the amortization of acquired intangible assets; Q2 FY25 restated to exclude the amortization of acquired intangible assets

Revenue increased approximately $1.0 million or 5.5% year-on-year reflecting an acquisition benefit of 8.1%, partially offset by an organic decline of 2.6% from lower demand at academic and research institutions that were impacted by NIH funding cuts. Adjusted operating income decreased approximately $0.2 million or 4.9% year-on-year due to the organic decline partially offset by contribution from the acquisition.

In fiscal third quarter 2026, on a sequential basis, the Company expects similar revenue and slightly lower adjusted operating margin due to product mix, investments in research and development, and tariff costs, partially offset by pricing and productivity initiatives.

**<u>Engraving (16% of sales; 13% of segment adjusted operating income)</u>**

---

| | | | |
|:---|:---|:---|:---|
|  | **2Q26** | **2Q25** | **% Change** |
| Engraving ($M) |  |  |  |
| Revenue | 35.7 | 31.5 | 13.6% |
| GAAP Operating Income | 6.6 | 4.1 | 59.3% |
| GAAP Operating Margin % | 18.4 | 13.1 |  |
| Adjusted Operating Income\* | 6.8 | 4.5 | 52.4% |
| Adjusted Operating Margin %\* | 19.2 | 14.3 |  |

---

\* Excludes the amortization of acquired intangible assets; Q2 FY25 restated to exclude the amortization of acquired intangible assets

------

Revenue increased approximately $4.3 million or 13.6% year-on-year reflecting organic growth of 10.3% from improved demand in Europe and North America and a foreign currency benefit of 3.3%. Adjusted operating income increased approximately $2.4 million or 52.4% year-on-year due to higher sales and the realization of previously announced productivity initiatives and restructuring actions.

In fiscal third quarter 2026, on a sequential basis, the Company expects similar revenue and slightly lower adjusted operating margin due to project and regional mix.

**<u>Specialty Solutions (9% of sales; 4% of segment adjusted operating income)</u>**

---

| | | | |
|:---|:---|:---|:---|
|  | **2Q26** | **2Q25** | **% Change** |
| Specialty Solutions ($M) |  |  |  |
| Revenue | 19.8 | 21.3 | -7.2% |
| Operating Income | 2.1 | 3.6 | -40.7% |
| Operating Margin % | 10.7 | 16.7 |  |

---

Specialty Solutions revenue decreased approximately $1.5 million or 7.2% year-on-year. Operating income decreased approximately $1.5 million or 40.7% year-on-year.

In fiscal third quarter 2026, on a sequential basis, the Company expects moderately to significantly higher revenue and operating margin.

**Capital Allocation**

● **Interest:** In fiscal third quarter 2026, the Company expects interest expense between $7 million and $7.5 million.

● **Share Repurchase**: During the fiscal second quarter of 2026, the Company did not repurchase shares. There was approximately $28 million remaining on the Company's current share repurchase authorization at the end of the fiscal second quarter 2026.

● **Capital Expenditures:** In fiscal second quarter 2026, the Company's capital expenditures were $7.7 million compared to $7.0 million in the fiscal second quarter of 2025. The Company expects fiscal year 2026 capital expenditures between $33 million and $38 million. Capital expenditures were $28.3 million in fiscal year 2025.

● **Dividend:** On January 23, 2026, the Company declared a quarterly cash dividend of $0.34 per share, an approximately 6.3% year-on-year increase. The dividend is payable February 27, 2026, to shareholders of record on February 13, 2026.

**Balance Sheet and Cash Flow Highlights**

● **Net Debt:** Standex had net (cash) debt of $437.7 million on December 31, 2025, compared to $413.2 million at the end of fiscal second quarter 2025. Net (cash) debt for the second quarter of 2026 consisted primarily of long-term debt of $534.7 million and cash and equivalents of $97.0 million.

● **Cash Flow:** Net cash provided by continuing operating activities for the three months ended December 31, 2025, was $20.7 million compared to $9.1 million in the prior year's quarter. Free cash flow after capital expenditures was $13.0 million compared to free cash flow after capital expenditures of $2.2 million in the fiscal second quarter of 2025.

------

*Conference Call Details* 

Standex will host a conference call for investors tomorrow, January 30, 2026, at 8:30 a.m. ET. On the call, David Dunbar, President and CEO, and Ademir Sarcevic, CFO, will review the Company's financial results and business and operating highlights. Investors interested in listening to the webcast and viewing the slide presentation should log on to the "Investors" section of Standex's website under the subheading, "Events and Presentations," located at www.standex.com.

A replay of the webcast will also be available on the Company's website shortly after the conclusion of the presentation online through January 30, 2027. To listen to the teleconference playback, please dial in the U.S. (888) 660-6345 or (646) 517-4150 internationally; the passcode is 80581#. The audio playback via phone will be available through February 6, 2026. The webcast replay can be accessed in the "Investor Relations" section of the Company's website, located at www.standex.com.

*Use of Non-GAAP Financial Measures*

In addition to the financial measures prepared in accordance with generally accepted accounting principles ("GAAP"), the Company uses certain non-GAAP financial measures, including non-GAAP adjusted income from operations, non-GAAP adjusted net income from continuing operations, free operating cash flow, EBITDA (earnings before interest, taxes, depreciation and amortization) adjusted EBITDA, adjusted EBITDA to net debt, and adjusted earnings per share. The attached financial tables reconcile non-GAAP measures used in this press release to the most directly comparable GAAP measures. The Company believes that the use of non-GAAP measures which exclude the impact of restructuring charges, purchase accounting, amortization from acquired intangible assets, insurance recoveries, discrete tax events, gain or loss on sale of a business unit, acquisition costs, and litigation costs help investors to obtain a better understanding of our operating results and prospects, consistent with how management measures and forecasts the Company's performance, especially when comparing such results to previous periods. An understanding of the impact in a particular quarter of specific restructuring costs, acquisition expenses, or other gains and losses, on net income (absolute as well as on a per-share basis), operating income or EBITDA can give management and investors additional insight into core financial performance, especially when compared to quarters in which such items had a greater or lesser effect, or no effect. Non-GAAP measures should be considered in addition to, and not as a replacement for, the corresponding GAAP measures, and may not be comparable to similarly titled measures reported by other companies.

**About Standex**

<u>Standex International Corporation</u> is a multi-industry manufacturer in five broad business segments: Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions with operations in the United States, Europe, Canada, Japan, Singapore, Mexico, Turkey, India, and China. For additional information, visit the Company's website at http://standex.com/.

------

*Forward-Looking Statements*

*Statements contained in this Press Release that are not based on historical facts are* "*forward-looking statements*" *within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terminology such as* "*should,*" "*could,*" "*may,*" "*will,*" "*expect,*" "*believe,*" "*estimate,*" "*anticipate,*" "*intend,*" "*continue,*" *or similar terms or variations of those terms or the negative of those terms. There are many factors that affect the Company*'*s business and the results of its operations and that may cause the actual results of operations in future periods to differ materially from those currently expected or anticipated. These factors include, but are not limited to: the impact of global crises or catastrophic events on employees, our supply chain, and the demand for our products and services around the world; materially adverse or unanticipated legal judgments, fines, penalties or settlements; conditions in the financial and banking markets, including fluctuations in exchange rates and the inability to repatriate foreign cash; domestic and international economic conditions, including the impact, length and degree of economic downturns on the customers and markets we serve and more specifically conditions in the electrical grid, automotive, construction, aerospace, defense, transportation, food service equipment, consumer appliance, energy, oil and gas and general industrial markets; lower-cost competition; the relative mix of products which impact margins and operating efficiencies in certain of our businesses; the impact of higher raw material and component costs, particularly steel, certain materials used in electronics parts, petroleum based products, and refrigeration components; the impact of higher transportation and logistics costs, especially with respect to transportation of goods from Asia; the impact of inflation on the costs of providing our products and services; an inability to realize the expected cost savings from restructuring activities including effective completion of plant consolidations, cost reduction efforts including procurement savings and productivity enhancements, capital management improvements, strategic capital expenditures, and the implementation of lean enterprise manufacturing techniques; the potential for losses associated with the exit from or divestiture of businesses that are no longer strategic or no longer meet our growth and return expectations; the inability to achieve the savings expected from global sourcing of raw materials and diversification efforts in emerging markets; the impact on cost structure and on economic conditions as a result of actual and threatened increases in trade tariffs; the inability to attain expected benefits from acquisitions and the inability to effectively consummate and integrate such acquisitions and achieve synergies envisioned by the Company; increased costs from acquisitions to improve and coordinate managerial, operational, financial, and administrative systems, including internal controls over financial reporting and compliance with the Sarbanes-Oxley Act of 2002, and other costs related to such systems in connection with acquired businesses; market acceptance of our products; our ability to design, introduce and sell new products and related product components; the ability to redesign certain of our products to continue meeting evolving regulatory requirements; the impact of delays initiated by our customers; our ability to increase manufacturing production to meet demand including as a result of labor shortages; the impact on our operations of any successful cybersecurity attacks; and potential changes to future pension funding requirements. For a more comprehensive discussion of these and other factors, see the* "*Risk Factors*" *section of the Company*'*s most recent annual report on Form 10-K filed with the SEC and available on the Company*'*s website. In addition, any forward-looking statements represent management's estimates only as of the day made and should not be relied upon as representing management's estimates as of any subsequent date. While the Company may elect to update forward-looking statements at some point in the future, the Company and management specifically disclaim any obligation to do so, even if management's estimates change.*

**Contact:** 

**Christopher Howe**

**Director of Investor Relations**

&nbsp;&nbsp;&nbsp;&nbsp;**(773) 754-5394**

**e-mail:** <u>InvestorRelations@Standex.com</u>

------

**Standex International Corporation**

**Consolidated Statement of Operations**

**(unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| (In thousands, except per share data) | **2025** | **2024** | **2025** | **2024** |
| Net sales<br>| $221320 | 189814 | $438751 | $360278 |
| Cost of sales | 129087 | 118367 | 256086 | 218758 |
| Gross profit | 92233 | 71447 | 182665 | 141520 |
| Selling, general and administrative expenses | 51166 | 42189 | 100998 | 83232 |
| Restructuring costs | 438 | 920 | 6436 | 2006 |
| Amortization of acquired intangible assets | 4439 | 3475 | 8976 | 5480 |
| Acquisition related costs | 617 | 16400 | 1049 | 18240 |
| Income from operations | 35573 | 8463 | 65206 | 32562 |
| Interest expense | 7914 | 5575 | 16826 | 6552 |
| Other non-operating (income) expense, net | 490 | 890 | 225 | 862 |
| Total | 8404 | 6465 | 17051 | 7414 |
| Income from continuing operations before income taxes | 27169 | 1998 | 48155 | 25148 |
| Provision for income taxes | 6536 | 710 | 11701 | 5672 |
| Net income from continuing operations | 20633 | 1288 | 36454 | 19476 |
| Income (loss) from discontinued operations, net of tax | 48 | (13) | 21 | (4) |
| Net income | 20681 | 1275 | 36475 | 19472 |
| Less: net income attributable to redeemable noncontrolling interest | 582 | 418 | 1321 | 418 |
| Less: change of redeemable noncontrolling interest to redemption value | 17979 |  | 17979 |  |
| Net income attributable to Standex International | $2120 | $857 | $17175 | $19054 |
| *Basic earnings per share:* | | | | |
| Income (loss) from discontinued operations | 0.00 | (0.00) | 0.00 | (0.00) |
| Total income (loss) attributable to Standex International | $0.17 | $0.07 | $1.43 | $1.60 |
| *Diluted earnings per share:* | | | | |
| Income (loss) from discontinued operations | 0.00 | (0.00) | 0.00 | (0.00) |
| Total income (loss) attributable to Standex International | $0.17 | $0.07 | $1.42 | $1.59 |
| *Average Shares Outstanding* | | | | |
| Basic | 12043 | 11942 | 12027 | 11872 |
| Diluted | 12055 | 12025 | 12073 | 11972 |

---

------

**Standex International Corporation**

**Condensed Consolidated Balance Sheets**

**(unaudited)**

---

| | | |
|:---|:---|:---|
|  | **December 31,** | **June 30,** |
| (In thousands) | **2025** | **2025** |
| **ASSETS**<br>|  |  |
| Current assets: |  |  |
| Cash and cash equivalents | $96998 | 104542 |
| Accounts receivable, net | 176628 | 172702 |
| Inventories | 131196 | 129994 |
| Prepaid expenses and other current assets | 85912 | 73641 |
| Total current assets | 490734 | 480879 |
| Property, plant, equipment, net | 160378 | 160364 |
| Intangible assets, net | 212052 | 225757 |
| Goodwill | 594080 | 610338 |
| Deferred tax asset | 11687 | 11971 |
| Operating lease right-of-use asset | 47835 | 47998 |
| Other non-current assets | 37735 | 29573 |
| Total non-current assets | 1063767 | 1086001 |
| Total assets | $1554501 | $1566880 |
| **LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND STOCKHOLDERS' EQUITY** | **LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND STOCKHOLDERS' EQUITY** |  |
| Current liabilities: |  |  |
| Accounts payable | $87773 | 88001 |
| Accrued liabilities | 69403 | 63204 |
| Income taxes payable | 13633 | 15770 |
| Total current liabilities | 170809 | 166975 |
| Long-term debt | 534733 | 552515 |
| Operating lease long-term liabilities | 37997 | 40057 |
| Accrued pension and other non-current liabilities | 66215 | 67743 |
| Total non-current liabilities | 638945 | 660315 |
| Redeemable non-controlling interest | 44511 | 27913 |
| Stockholders' equity: |  |  |
| Common stock | 41976 | 41976 |
| Additional paid-in capital | 140476 | 136082 |
| Retained earnings | 1136096 | 1126851 |
| Accumulated other comprehensive loss | (188019) | (164765) |
| Treasury shares | (430293) | (428467) |
| Total stockholders' equity | 700236 | 711677 |
| Total liabilities, redeemable noncontrolling interest and stockholders' equity | $1554501 | $1566880 |

---

------

**Standex International Corporation and Subsidiaries**

**Statements of Consolidated Cash Flows**

**(unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Six Months Ended** | **Six Months Ended** |
|  | **December 31,** | **December 31,** |
| (In thousands) | **2025** | **2024** |
| **Cash Flows from Operating Activities** |  |  |
| Net income | $36475 | 19472 |
| Income (loss) from discontinued operations | 21 | (4) |
| Income from continuing operations | 36454 | 19476 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Adjustments to reconcile net income to net cash provided by operating activities: |  |
| Depreciation and amortization | 19801 | 15566 |
| Stock-based compensation | 4838 | 5155 |
| Non-cash portion of restructuring charge | 149 | (896) |
| Contributions to defined benefit plans | (2796) | (4766) |
| Net changes in operating assets and liabilities | (20935) | (7873) |
| Net cash provided by operating activities - continuing operations | 37511 | 26662 |
| Net cash provided by (used in) operating activities - discontinued operations | (127) | (31) |
| Net cash provided by (used in) operating activities | 37384 | 26631 |
| **Cash Flows from Investing Activities** |  |  |
| Expenditures for property, plant and equipment | (14084) | (13690) |
| Expenditures for acquisitions, net of cash acquired |  | (419652) |
| Other investing activities | (5) | 3904 |
| Net cash provided by (used in) investing activities | (14089) | (429438) |
| **Cash Flows from Financing Activities** |  |  |
| Proceeds from borrowings | 8000 | 724313 |
| Payments of debt | (26000) | (339110) |
| Contingent consideration payment | (330) |  |
| Activity under share-based payment plans | 1528 | 1791 |
| Purchase of treasury stock and other | (3798) | (5166) |
| Distributions to non-controlling interests | (1598) |  |
| Cash dividends paid | (7930) | (7362) |
| Other financing activities |  | (4415) |
| Net cash provided by (used in) financing activities | (30128) | 370051 |
| Effect of exchange rate changes on cash | (711) | (300) |
| Net changes in cash and cash equivalents | (7544) | (33056) |
| Cash and cash equivalents at beginning of year | 104542 | 154203 |
| Cash and cash equivalents at end of period | $96998 | $121147 |

---

------

**Standex International Corporation**

**Selected Segment Data**

**(unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| (In thousands) | **2025** | **2024** | **2025** | **2024** |
| <u>**Net Sales**</u> |  |  |  |  |
| Electronics | $115668 | $95923 | $226220 | $173656 |
| Engineering Technologies | 30636 | 22649 | 60530 | 43179 |
| Scientific | 19502 | 18477 | 38952 | 36170 |
| Engraving | 35728 | 31454 | 71568 | 64817 |
| Specialty Solutions | 19786 | 21311 | 41481 | 42456 |
| Total | $221320 | $189814 | $438751 | $360278 |
| **<u>Income from operations</u>** |  |  |  |  |
| Electronics | $29765 | $17419 | $58048 | $34446 |
| Engineering Technologies | 4377 | 3692 | 7994 | 7702 |
| Scientific | 4488 | 4718 | 9167 | 9467 |
| Engraving | 6568 | 4122 | 13104 | 9946 |
| Specialty Solutions | 2112 | 3562 | 5000 | 7110 |
| Restructuring | (438) | (920) | (6436) | (2006) |
| Acquisition related costs | (617) | (16400) | (1049) | (18240) |
| Corporate | (10682) | (7730) | (20622) | (15863) |
| Total | $35573 | $8463 | $65206 | $32562 |

---

------

**Standex International Corporation**

**Reconciliation of GAAP to Non-GAAP Financial Measures**

**(unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |  |  | **Six Months Ended** | **Six Months Ended** |  |  |
|  | **December 31,** | **December 31,** |  |  | **December 31,** | **December 31,** |  |  |
| (In thousands, except percentages) | **2025** | **2024** | **%** <br> **Change** |  | **2025** | **2024** | **%** <br> **Change** |  |
| *Adjusted income from operations and adjusted net income from continuing operations:* | | | | | | | | |
| **Net Sales** | $221320 | $189814 | 16.6 | % | $438751 | $360278 | 21.8 | % |
| **Income from operations, as reported** | $35573 | $8463 | 320.3 | % | $65206 | $32562 | 100.3 | % |
| Income from operations margin | 16.1 | 4.5 |  |  | 14.9 | 9.0 |  |  |
| Adjustments: |  |  |  |  |  |  |  |  |
| Restructuring charges | 438 | 920 |  |  | 6436 | 2006 |  |  |
| Acquisition-related costs | 617 | 16400 |  |  | 1049 | 18240 |  |  |
| Amortization of acquired intangible assets | 4439 | 3475 |  |  | 8976 | 5480 |  |  |
| Litigation (settlement refund) charge | 100 |  |  |  | 100 |  |  |  |
| Purchase accounting expenses | 993 | 6197 |  |  | 1985 | 6197 |  |  |
| **Adjusted income from operations** | $42160 | $35455 | 18.9 | % | $83752 | $64485 | 29.9 | % |
| Adjusted income from operations margin | 19.0 | 18.7 |  |  | 19.1 | 17.9 |  |  |
| Interest and other income (expense), net | (8404) | (6465) |  |  | (17051) | (7414) |  |  |
| Foreign currency related (gain) loss on acquisition and divestiture activities |  | 554 |  |  |  | 554 |  |  |
| Provision for income taxes | (6536) | (710) |  |  | (11701) | (5672) |  |  |
| Discrete and other tax items |  | 447 |  |  |  | 375 |  |  |
| Tax impact of above adjustments | (1561) | (5958) |  |  | (4566) | (7141) |  |  |
| **Net income from continuing operations, as adjusted** | 25659 | 23323 |  |  | 50434 | 45187 |  |  |
| Less: net income attributable to redeemable noncontrolling interest | 18561 | 418 |  |  | 19300 | 418 |  |  |
| Add back: change of redeemable noncontrolling interest to redemption value per the acquisition agreement | (17979) |  |  |  | (17979) |  |  |  |
| **Net income from continuing operations attributable to Standex, as adjusted** | $25077 | $22905 | 9.5 | % | $49113 | $44769 | 9.7 | % |
| *EBITDA and Adjusted EBITDA:* | | | | | | | | |
| **Net income (loss) from continuing operations, as reported** | $20633 | $1288 | 1501.9 | % | $36454 | $19476 |  |  |
| Net income from continuing operations margin | 9.3 | 0.7 |  |  | 8.3 | 5.4 |  |  |
| Add back: |  |  |  |  |  |  |  |  |
| Provision for income taxes | 6536 | 710 |  |  | 11701 | 5672 |  |  |
| Interest expense | 7914 | 5575 |  |  | 16826 | 6552 |  |  |
| Depreciation and amortization | 9984 | 8505 |  |  | 19801 | 15566 |  |  |
| **EBITDA** | $45067 | $16078 | 180.3 | % | $84782 | $47266 | 79.4 | % |
| EBITDA Margin | 20.4 | 8.5 |  |  | 19.3 | 13.1 |  |  |
| Adjustments: |  |  |  |  |  |  |  |  |
| Restructuring charges | 438 | 920 |  |  | 6436 | 2006 |  |  |
| Acquisition-related costs | 617 | 16400 |  |  | 1049 | 18240 |  |  |
| Litigation (settlement refund) charge | 100 |  |  |  | 100 |  |  |  |
| Purchase accounting expenses | 993 | 6197 |  |  | 1985 | 6197 |  |  |
| **Adjusted EBITDA** | $47214 | $39595 | 19.2 | % | $94352 | $73709 | 28.0 | % |
| Adjusted EBITDA Margin | 21.3 | 20.9 |  |  | 21.5 | 20.5 |  |  |
| *Free operating cash flow:* | | | | | | | | |
| **Net cash provided by operating activities - continuing operations, as reported** | $20703 | $9115 |  |  | $37511 | $26662 |  |  |
| Less: Capital expenditures | (7664) | (6965) |  |  | (14084) | (13690) |  |  |
| **Free cash flow from continuing operations** | $13039 | $2150 |  |  | $23427 | $12972 |  |  |

---

------

**Standex International Corporation**

**Reconciliation of GAAP to Non-GAAP Financial Measures**

**(unaudited)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |  | **Six Months Ended** | **Six Months Ended** |  |
|  | **December 31,** | **December 31,** |  | **December 31,** | **December 31,** |  |
| *Adjusted earnings per share from continuing operations* | **2025** | **2024** | **%**<br> **Change** | **2025** | **2024** | **% Change** |
| **Diluted earnings per share from continuing operations attributable to Standex, as reported** | $0.17 | $0.07 | 145.6% | $1.42 | $1.59 | -10.6% |
| Adjustments: |  |  |  |  |  |  |
| Restructuring charges | 0.03 | 0.06 |  | 0.39 | 0.13 |  |
| Acquisition-related costs | 0.04 | 1.10 |  | 0.07 | 1.22 |  |
| Amortization of acquired intangible assets | 0.28 | 0.22 |  | 0.57 | 0.35 |  |
| Gain on bargain purchase |  |  |  |  |  |  |
| Litigation (settlement refund) charge | 0.01 |  |  | 0.01 |  |  |
| (Gain) loss on sale of business |  |  |  |  |  |  |
| Foreign currency related (gain) loss on acquisition and divestiture activities |  | 0.03 |  |  | 0.03 |  |
| Environmental remediation |  |  |  |  |  |  |
| Discrete tax items |  | 0.04 |  |  | 0.04 |  |
| Purchase accounting expenses | 0.06 | 0.39 |  | 0.13 | 0.39 |  |
| Change of redeemable noncontrolling interest to redemption value per the acquisition agreement | 1.49 |  |  | 1.49 |  |  |
| **Diluted earnings per share from continuing operations attributable to Standex, as adjusted** | $2.08 | $1.91 | 8.9% | $4.08 | $3.75 | 8.8% |

---